While humans evolved to perform routine endurance activity, recent secular trends in the United States and globally have resulted in a dramatic rise in the amount of time spent inactive in both ...

View post: How Skiing Builds Serious Strength—and Why Stowe Is the Best Place to Do It in the East View post: The North Face's Top-Rated Fleece Jacket is Now 50% Off During REI's End of Year Sale The ...

Eli Lilly and Company delivered best-in-class weight loss data for retatrutide, reinforcing its dominance in obesity and diabetes therapeutics. Retatrutide achieved up to 28.7% average weight loss and ...

Eli Lilly LLY0.50%increase; green up pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...

(OSV News) — In 1937, leaders of the pharmaceutical giant Eli Lilly and Company in Indianapolis established a philanthropic foundation created to support Christian seminaries. Lilly Endowment Inc.

see more of our stories on Google. Add Axios on Google Eli Lilly CEO David Ricks, at left, said drugs manufactured at the site are on the "cutting edge of what's happening in medicine." Photo: Derek ...

Eli Lilly LLY-0.45%decrease; red down pointing triangle plans to build a $6 billion facility in Huntsville, Ala., to make active pharmaceutical ingredients, including those used in weight-loss drugs.

HUNTSVILLE, Ala. (WHNT) — Pharmaceutical giant Eli Lilly announced on Tuesday it plans to invest more than $6 billion in a new manufacturing plant in Huntsville. Company officials said the site will ...

Dec 9 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S.